Eledon Pharmaceuticals (ELDN) closed at $2.76 on November 10, 2026, down 3.8% from the previous close, on volume of 669,634 shares (30-day average 843,339).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
NewcelX prices $1.55M share offering at $3.29 to fund diabetes program
Seeking Alpha News (Mon, 9-Nov 10:09 AM ET)
Globe Newswire (Mon, 26-Oct 7:00 AM ET)
Globe Newswire (Mon, 5-Oct 4:05 PM ET)
Market Chameleon (Tue, 22-Sep 7:37 AM ET)
Globe Newswire (Tue, 22-Sep 7:00 AM ET)
Globe Newswire (Wed, 9-Sep 7:00 AM ET)
Globe Newswire (Thu, 3-Sep 7:00 AM ET)
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Market Chameleon (Mon, 22-Jun 7:47 AM ET)
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
Eledon Pharmaceuticals trades on the NASDAQ stock market under the symbol ELDN.
As of November 10, 2026, ELDN stock price declined to $2.76 with 669,634 million shares trading.
ELDN has a beta of 3.02, meaning it tends to be more sensitive to market movements. ELDN has a correlation of 0.14 to the broad based SPY ETF.
ELDN has a market cap of $224.28 million. This is considered a Small Cap stock.
In the last 3 years, ELDN traded as high as $5.54 and as low as $1.11.
The top ETF exchange traded funds that ELDN belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
ELDN has outperformed the market in the last year with a price return of +22.7% while the SPY ETF gained +11.2%. However, in the short term, ELDN had mixed performance relative to the market. It has underperformed in the last 3 months, returning -25.0% vs -2.7% return in SPY. But in the last 2 weeks, ELDN shares have fared better than the market returning +14.5% compared to SPY -2.6%.
ELDN support price is $2.70 and resistance is $3.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELDN shares will trade within this expected range on the day.
